本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kazia Therapeutics Limited

3.30
-0.2395-6.77%
盤後3.29-0.0100-0.30%19:27 EDT
成交量:19.64萬
成交額:68.78萬
市值:459.97萬
市盈率:-0.10
高:4.16
開:3.41
低:2.86
收:3.54
資料載入中...
2025/02/03

SEC問詢函

Form CORRESP - Correspondence
2025/01/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/15

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/06/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/06/01

SEC問詢函

Form CORRESP - Correspondence
2024/05/29

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/03

SEC問詢函

Form CORRESP - Correspondence
2024/01/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/07

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/09/07

SEC問詢函

CORRESP [Cover] - Correspondence